CLXClorox Company — stock analysis & sentiment
Clorox Company (CLX) last closed at $83.10, near the bottom of its 52-week range of $83.09–$128.90. Composite market sentiment across 2 analyses is neutral (-9 on a −100 to +100 scale), as of Sep 20, 2026.
Produced by the Synoptiv Research Engine from public financial data. Read the methodology.
Go beyond the overview
The thesis, technical signals, risk levels, and complete evidence — everything the overview leaves out.
What changed
Since the previous analysis (v1) on Aug 1, 2026.
CLX fell to $83.10, from $95.53 at the previous analysis.
Composite sentiment ticked down from -7 to -9, still neutral.
42 headlines since the last analysis — 4 positive, 2 negative, 36 neutral.
P/E (TTM) rose +9.96%, from 15.7 to 17.3.
The written analysis on this page was refreshed for v2.
What the data says
An overview of the public data behind CLX.
At $83.10, the stock closed within a cent of its 52-week low of $83.09 and roughly 36% below the $128.90 high at the other end of that range. A band that wide for a consumer staples name means the past year has covered a lot of ground, and the current price sits at the bottom edge of it rather than anywhere in the middle.
The market is carrying the business at about $10.0 billion, or 17.3 times trailing earnings and 13.3 times forward estimates — a gap that reflects expectations of higher earnings ahead than the last twelve months produced. Profitability is modest in absolute terms, with a net margin near 8.7% on revenue that has contracted about 2% year over year. Price-to-book of roughly 112 is a function of a very thin equity base rather than a normal balance-sheet read, so it carries little information on its own here. The dividend yield stands at 6.02%, and a beta of 0.54 places the shares at about half the market's volatility, the low-correlation behavior typical of the Consumer Defensive sector.
Recent coverage is mostly company-specific and clusters around two themes: valuation screens pitting Clorox against another household-products name, and its dividend record, including its standing among long-running dividend raisers and lists of stocks trading near 52-week lows. A September piece noted the shares were down 9.3% since the last earnings report. The one broader item — a Newsweek trustworthiness ranking — names other companies in their industries rather than Clorox itself, so the flow as a whole centers on this company more than on its sector.
Written from public market data. Research, not financial advice — the thesis, signals and risk levels are in the full report.
Price chart
CLX daily price history.
Market sentiment
A composite of the public market data in this analysis, from −100 (bearish) to +100 (bullish).
This gauge blends news tone, analyst views, insider and congressional activity, and price momentum into a single score. The full report breaks down each driver and pairs it with the thesis.
See the full sentiment breakdown in the report →Key stats
A public snapshot of commonly used market and valuation measures.
Valuation & size
- Market cap
- $10.05B
- Enterprise value
- $15.67B
- P/E (TTM)
- 17.28
- Forward P/E
- 13.27
- Price / book
- 111.69
Profitability & growth
- Net margin
- 8.73%
- Revenue growth
- -2.00%
- Earnings growth
- -50.10%
- Dividend yield
- 6.02%
Price & risk
- Beta
- 0.54
- Average volume
- 2.76M
From noise to signal. The full report has CLX’s thesis, trade signal, and risk levels.
About Clorox Company
The Clorox Company makes consumer and professional cleaning, household, and personal care products, organized into four segments: Health and Wellness, Household, Lifestyle, and International. Its cleaning and disinfecting lines include the namesake Clorox bleach and wipes along with Pine-Sol, Tilex, Formula 409, and Liquid-Plumr, plus hand hygiene and professional food service offerings sold under Purell, GOJO, CloroxPro, and Clorox Healthcare. Other well-known brands span Glad bags and wraps, Fresh Step and Scoop Away cat litter, Kingsford charcoal, Hidden Valley dressings and seasonings, Brita water filtration, and Burt's Bees natural personal care. Outside the United States, the company sells under regional names such as Poett and Clorinda. Products reach customers through mass retailers, grocery stores, warehouse clubs, dollar stores, home improvement and hardware outlets, drug and pet stores, distributors, and both third-party and company-operated e-commerce channels. Clorox was founded in 1913 and is headquartered in Oakland, California.
Latest news
Recent headlines related to CLX, with vendor tone.
CLX — frequently asked questions
Answered from the public data on this page.
What is the current market sentiment for CLX?
As of Sep 20, 2026, Clorox Company (CLX) carries neutral (-9 on a −100 to +100 scale) composite sentiment. The score fuses recent news tone, analyst recommendations, technical posture, insider and congressional activity, and market attention into a single figure. The full breakdown of each component is in the report.
How has CLX stock been performing?
Clorox Company last closed at $83.10, near the bottom of its 52-week range of $83.09–$128.90.
What is CLX's market cap and valuation?
Clorox Company has a market capitalization of about $10.05B, a trailing P/E of 17.3, a dividend yield of 6.02%.
What sector is CLX in, and who are its competitors?
Clorox Company operates in the Consumer Defensive sector, specifically Household & Personal Products. Comparable companies include PG, CL, KMB, CHD, REYN.
Where can I find a full analysis of CLX?
The full CLX report covers the bull and bear cases, technical signals with entry, stop and target levels, complete financial statements, earnings history, insider and congressional trades, and the conditions that would invalidate the thesis. It requires a free account.
Analysis history
Every saved analysis, newest first.